| mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
1e-06 |
| mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
2e-06 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
5e-06 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
6e-06 |
| mRNA |
Y-39983 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
9e-06 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
4e-05 |
| mRNA |
Ispinesib Mesylate |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
5e-05 |